In pancreatic carcinomas, IL-33 drives ILC2 activation, which promotes CD103+ dendric cell recruitment through the production of CCL-5 and, consequently, CD8+ T cell activation [33]. The gene discussed is CD8A; the disease is exocrine pancreatic carcinoma.